Omeros Nabs Michael J. Fox Grant

Xconomy Seattle — 

Omeros, a Seattle-based drug developer, said it has received a $465,000 grant from the Michael J. Fox Foundation for Parkinson’s Research. The grant will pay for research of a new target on brain cells discovered by Omeros scientists, which has been linked to movement disorders like Parkinson’s and Restless Leg Syndrome.